Discovery of imidazole carboxamides as potent and selective CCK1R agonists

The discovery and optimization of a novel class of 1,2-diaryl imidazole carboxamides as CCK1R agonists are reported. Compound 44 exhibited excellent lean mouse overnight food intake reduction. High-throughput screening revealed diaryl pyrazole 3 as a selective albeit modest cholecystokinin 1 recepto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2008-08, Vol.18 (15), p.4393-4396
Hauptverfasser: Zhu, Cheng, Hansen, Alexa R., Bateman, Thomas, Chen, Zhesheng, Holt, Tom G., Hubert, James A., Karanam, Bindhu V., Lee, Susan J., Pan, Jie, Qian, Su, Reddy, Vijay B.G., Reitman, Marc L., Strack, Alison M., Tong, Vincent, Weingarth, Drew T., Wolff, Michael S., MacNeil, Doug J., Weber, Ann E., Duffy, Joseph L., Edmondson, Scott D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The discovery and optimization of a novel class of 1,2-diaryl imidazole carboxamides as CCK1R agonists are reported. Compound 44 exhibited excellent lean mouse overnight food intake reduction. High-throughput screening revealed diaryl pyrazole 3 as a selective albeit modest cholecystokinin 1 receptor (CCK1R) agonist. SAR studies led to the discovery and optimization of a novel class of 1,2-diaryl imidazole carboxamides. Compound 44, which was profiled extensively, showed good in vivo mouse gallbladder emptying (mGBE) and lean mouse overnight food intake (ONFI) reduction activities.
ISSN:0960-894X
0968-0896
1464-3405
1464-3391
DOI:10.1016/j.bmcl.2008.06.057